MIRM

Mirum Pharmaceuticals News

Company Name Stock Ticker Symbol Market Type
Mirum Pharmaceuticals Inc MIRM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.03 -0.12% 24.45 10:34:50
Open Price Low Price High Price Close Price Prev Close
24.24 24.10 24.87 24.48
more quote information »

Recent News

Date Time Source Heading
8/16/202212:21EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
8/12/202216:30BWMirum Pharmaceuticals Announces Closing of Public Offering..
8/11/202206:25TRMNMirum Pharmaceuticals (MIRM) Receives a Buy from H.C...
8/10/202223:59BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
8/10/202217:08EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
8/09/202221:33BWMirum Pharmaceuticals Announces Pricing of Public Offering..
8/09/202216:22EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
8/09/202216:11BWMirum Pharmaceuticals Announces Commencement of Public..
8/04/202216:35EDGARQuarterly Report (10-q)
8/04/202216:04EDGARCurrent Report Filing (8-k)
8/04/202216:01BWMirum Pharmaceuticals Reports Second Quarter 2022 Financial..
7/28/202209:00BWMirum Pharmaceuticals to Announce Second Quarter 2022..
7/27/202205:14TRMNSVB Securities Sticks to Its Buy Rating for Mirum..
7/08/202221:00BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
6/26/202216:23BWMirum Pharmaceuticals stellt auf der Jahrestagung der..
6/26/202207:09BWMirum Pharmaceuticals stellt neue Daten auf dem..
6/26/202200:41BWMirum Pharmaceuticals met en évidence des données démontrant..
6/25/202220:41BWMirum Pharmaceuticals présente de nouvelles données à..
6/24/202208:00BWMirum Pharmaceuticals Highlights Data Demonstrating Impact..
6/24/202203:00BWMirum Pharmaceuticals Presents New Data at The International..
6/13/202208:30BWMirum Pharmaceuticals to Showcase LIVMARLI® (maralixibat)..
6/10/202220:00BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
6/08/202219:26EDGARStatement of Changes in Beneficial Ownership (4)
6/06/202218:09EDGARStatement of Changes in Beneficial Ownership (4)
6/06/202218:07EDGARStatement of Changes in Beneficial Ownership (4)
6/06/202218:04EDGARStatement of Changes in Beneficial Ownership (4)
6/06/202218:01EDGARStatement of Changes in Beneficial Ownership (4)
6/06/202218:00EDGARStatement of Changes in Beneficial Ownership (4)
6/06/202217:57EDGARStatement of Changes in Beneficial Ownership (4)
6/06/202217:55EDGARStatement of Changes in Beneficial Ownership (4)
6/06/202208:32EDGARCurrent Report Filing (8-k)
6/06/202208:30BWMirum Pharmaceuticals Appoints Saira Ramasastry to Board of..
5/25/202216:34EDGARSecurities Registration Statement (simplified Form) (s-3)
5/24/202204:35TRMNMirum Pharmaceuticals (MIRM) Received its Third Buy in a Row
5/23/202209:01EDGARCurrent Report Filing (8-k)
5/23/202208:30BWMirum Pharmaceuticals Acquires Satiogen Pharmaceuticals
5/21/202208:05TRMNAnalysts Offer Insights on Healthcare Companies: Mirum..
5/18/202218:30BWMirum Pharmaceuticals to Participate in Upcoming Investor..
5/10/202220:05BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
5/08/202211:17TRMNSVB Securities Remains a Buy on Mirum Pharmaceuticals (MIRM)
5/06/202223:33TRMNRobert W. Baird Maintains Their Buy Rating on Mirum..
5/06/202208:38TRMNMirum Pharmaceuticals (MIRM) Receives a Buy from Raymond..
5/05/202216:11EDGARQuarterly Report (10-q)
5/05/202208:07EDGARCurrent Report Filing (8-k)
5/05/202208:00BWMirum Pharmaceuticals Reports First Quarter 2022 Financial..
5/02/202216:05BWMirum Pharmaceuticals to Announce First Quarter 2022..
4/26/202223:08TRMNEvercore ISI Believes Mirum Pharmaceuticals (MIRM) Still Has..
4/26/202212:36TRMNLeerink Partners Believes Mirum Pharmaceuticals (MIRM) Won’t..
4/22/202216:33EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/08/202218:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..


Your Recent History
NASDAQ
MIRM
Mirum Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now